Pegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infection
A. L. Bailey, C. R. Buechler, D. R. Matson, E. J. Peterson, K. G. Brunner, M. S. Mohns, M. Breitbach, L. M. Stewart, A. J. Ericsen, S. Capuano, H. A. Simmons, D. T. Yang, D. H. O'Connor
Abstract
Human pegivirus (HPgV) protects HIV+ people from HIV-associated disease, but the mechanism of this protective effect remains poorly understood. We sequentially infected cynomolgus macaques with simian pegivirus (SPgV) and simian immunodeficiency virus (SIV) to model HIV+HPgV co-infection. SPgV had no effect on acute-phase SIV pathogenesis - as measured by SIV viral load, CD4+ T cell destruction, and immune activation - suggesting that HPgVs protective effect is exerted primarily during the chronic phase of HIV infection. We also examined the immune response to SPgV in unprecedented detail, and found that this virus elicits virtually no activation of the immune system despite persistently high titers in the blood over long periods of time. Overall, this study expands our understanding of the pegiviruses - an understudied group of viruses with a high prevalence in the global human population - and suggests that the protective effect observed in HIV+HPgV co-infected people occurs primarily during the chronic phase of HIV infection.\n\nOne Sentence SummaryPegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infection.\n\nShort TitlePegivirus and AIDS-virus co-infection\n\nAccessible SummaryPeople infected with HIV live longer, healthier lives when they are co-infected with the human pegivirus (HPgV) - an understudied virus with a high prevalence in the global human population. To better understand how HPgV protects people with HIV from HIV-associated disease, we infected macaques with simian versions of these two viruses (SPgV and SIV). We found that SPgV had no impact on the incidence of SIV-associated disease early during the course of SIV infection - a time when SIV and HIV are known to cause irreversible damage to the immune system. Oddly, we found that the immune system did not recognize SPgV; a finding that warrants further investigation. Overall, this study greatly expands on our understanding of the pegiviruses and their interaction with the immune system.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Immune determinants of pegivirus persistence, control, and cross-species infection in the laboratory mouse
Kylie Nennig, Satyapramod Srinivasa Murthy, … Adam L. Bailey·PLoS PathogensPeer-reviewed·Aug 28, 2024
- Title: Combinatorial bnAb and T Cell Immunization Enhances Post-Infection Control of SHIVSF162p3 Viremia in Rhesus Macaques
Diane G Carnathan, Chiamaka A Enemuo, … George K Lewis·bioRxiv·Nov 5, 2026
- Mucosal immune stimulation with HSV-2 and polyICLC boosts control of viremia in SIVΔNef vaccinated rhesus macaques with breakthrough SIV infection
M. Aravantinou, O. Mizenina, … N. Derby·bioRxiv·Jun 2, 2020
- Chronic innate immune impairment and ZIKV persistence in the gastrointestinal tract during SIV infection in pigtail macaques
Jennifer Tisoncik-Go, Thomas B. Lewis, … Megan A. O’Connor·Frontiers in ImmunologyPeer-reviewed·Mar 4, 2025
- Long term sterile immunity induced by an adjuvant-containing live-attenuated AIDS virus
T. Okamura, Y. Shimizu, … Y. Yasutomi·bioRxiv·May 22, 2020
- SIV/SHIV-Zika coinfection does not alter disease pathogenesis in adult non-pregnant Rhesus Macaques
M. Bidokhti, D. Dutta, … S. Byrareddy·bioRxiv·Jun 15, 2018